McKenna D.J., Towers G.H.N., Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca Journal of Ethnopharmacology, vol 10 ano 2 (195–223), 1984, April Disponível em pdf[ligação inativa] Jan.2011
Fontanilla, Dominique et al. “The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator.” Science (New York, N.Y.) 323.5916 (2009): 934–937. PMC. Web. PDF 11 Dec. 2014.
Cozzi N.V., Gopalakrishnan A., Anderson L.L., Feih J.T., Shulgin A.T., Daley P.F., Ruoho A.E. (December 2009). "Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter"(PDF, Jan. 2011)Arquivado em 17 de junho de 2010, no Wayback Machine.. Journal of Neural Transmission 116 (12): 1591–9.
Cozzi N.V., Gopalakrishnan A., Anderson L.L., Feih J.T., Shulgin A.T., Daley P.F., Ruoho A.E. (December 2009). "Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter"(PDF, Jan. 2011)Arquivado em 17 de junho de 2010, no Wayback Machine.. Journal of Neural Transmission 116 (12): 1591–9.